Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies

Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies

Understanding of the molecular mechanisms of prostate cancer has led to development of therapeutic strategies targeting androgen receptor (AR). These androgen-receptor signaling inhibitors (ARSI) include androgen synthesis inhibitor-abiraterone and androgen receptor antagonists-enzalutamide, apaluta...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aasems Jacob, Rishi Raj, Derek B. Allison, Zin W. Myint
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
prostate cancer
castrate-resistant growth
metastases
androgen receptor
glucocorticoid receptor
cytokines
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/be6b500cf3f34a71965605d8b1c7087c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/be6b500cf3f34a71965605d8b1c7087c

Ejemplares similares